Lunit

Lunit Assets per Share

The Total Assets per Share of Lunit (328130.KQ) as of Oct 16, 2026 is 40.66 KRW. In the previous year, Total Assets per Share was 32.92 KRW — a change of 23.52% (higher).

Assets per Share

40.66KRW

YoY

23.52%

Last updated:

Total Assets per Share of Lunit is 2024 40.66 KRW. Total Assets per Share of Lunit was 2023 32.92 KRW. It decreases by 23.52% higher compared to the previous year.

The Lunit Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2019
92.43 KRW
Jan 1, 2020
60.46 KRW
Jan 1, 2021
225.83 KRW
Jan 1, 2022
21.57 KRW
Jan 1, 2023
32.92 KRW
Jan 1, 2024
40.66 KRW
The Lunit Assets per Share history
YEARAssets per ShareYoY
40.66KRW+23.52%
32.92KRW+52.61%
21.57KRW-90.45%
225.83KRW+273.54%
60.46KRW-34.59%
92.43KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lunit Stock analysis

What does Lunit do? Lunit Inc is a South Korean company headquartered in Seoul, operating within the Health Care sector. The company has 293 employees and went public on July 21, 2022, with its ticker listed as 328130.KQ and ISIN KR7328130000. Lunit provides software solutions for medical diagnostic imaging services, focusing on the development and supply of AI-powered medical software. Its offerings include cancer diagnostic aid solutions, cancer early detection solutions, and cancer risk prediction solutions. The company's technology leverages artificial intelligence to enhance diagnostic capabilities in healthcare settings. Lunit's website is www.lunit.io, where further information about its services and solutions can be accessed. The company operates in the Health Care industry, specifically targeting medical imaging and AI-driven diagnostic tools. As of the latest available data, Lunit is engaged in the development and commercialization of AI-based medical software, aiming to improve the accuracy and efficiency of cancer-related diagnostics. The firm's IPO date marks its transition to a publicly traded company, reflecting its growth and market position in the healthcare technology space. Lunit's focus on AI applications in medical imaging positions it as a key player in the digital health sector, particularly within the Korean market and beyond. The company's solutions are designed to support healthcare professionals in making more informed diagnostic decisions, potentially reducing the time and resources required for cancer detection and treatment planning. Lunit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lunit stock

Total Assets per Share of Lunit is 40.66 KRW in 2024.

Total Assets per Share of Lunit changed from 32.92 KRW to 40.66 KRW, representing a 23.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Lunit since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Lunit

All Key Metrics — Lunit